[Correspondence] An open letter to Michael Ball, Chief Executive of Hospira Pharmaceuticals – Response from Hospira
Source: The Lancet
Hospira shares the concern over improper use of our drugs in US executions. Hospira has long communicated that we do not support the use of any of our products in lethal injections—a use that is clearly outside the licensing approved by the Food and Drug Administration and completely counter to our company vision of advancing wellness. In fact, over the years, Hospira has regularly written to every US state to make clear that we oppose the use of our drugs, including pancuronium bromide, in executions, and we have stated our opposition publicly through the media innumerable times.
